SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-19-000014
Filing Date
2019-01-10
Accepted
2019-01-10 16:31:50
Documents
1
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5975
  Complete submission text file 0000903423-19-000014.txt   7657
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 203-863-5000
Viking Global Equities Master Ltd. (Reporting) CIK: 0001759530 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 19520546